Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octanoic Acid for Essential Voice Tremor
NCT01864525Phase 2Completed
- Sponsor
- Syracuse University
- Start
- Jul 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in essential tremor (ET) comparing Octanoic acid with Placebo (2 arms). Primary endpoints: Magnitude of Acoustic Amplitude Tremor at 3 weeks and Magnitude of Acoustic Frequency Tremor at 3 weeks. Started Jul 2013; status: completed.
02
Drugs
Octanoic acid
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT01864525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01864525.